课题基金 / 基金详情

A PHASE II DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE

A PHASE II DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE
一项 II 期双盲、随机、安慰剂对照研究来评估
批准号：
7717987
负责人：
RONALD T. MITSUYASU
金额：
$0.35万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-12-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7717987
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseDouble-Blind MethodFundingGrantInstitutionInterruptionPhasePlacebosResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthVaccinesViralWeekrandomized placebo controlled trial

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 主要目标： 为了确定MRK Ad5疫苗与安慰剂相比，在ART中断后超过16周的ART中断后是否具有维持病毒抑制的效果。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Primary Objective: To determine if the MRK Ad5 vaccine has an effect of maintaining viral suppression following interruption of ART over 16 weeks post-ART interruption, versus placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)